Search research articles
Contact Us
Filters
Showing results (11-20 of 148) with videos related to
Page
of 15
Sort By:
Journal of Indian Philosophy
|
November 1, 2021
The Impact of Navya-Nyāya on Mādhva Vedānta: Vyāsatīrtha and the Problem of Empty Terms
Michael Thomas Williams
Nature Reviews. Neurology
|
September 22, 2022
Beyond ocrelizumab in primary progressive multiple sclerosis
Thomas Williams, Jeremy Chataway
The Lancet. Infectious Diseases
|
January 23, 2025
RSV vaccines: an elixir for healthy ageing?
Harish Nair, Thomas Williams
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 4, 2018
Immune-mediated encephalitis with daclizumab: The final nail
Thomas Williams, Jeremy Chataway
Journal of Medical Case Reports
|
September 21, 2012
Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report
Thomas Williams, John Thorpe
Journal of Visualized Experiments : Jove
|
September 25, 2018
High-throughput Measurement of Dictyostelium discoideum Macropinocytosis by Flow Cytometry
Thomas Williams, Robert R Kay
Frontiers in Research Metrics and Analytics
|
September 22, 2025
The online survey in qualitative research: can AI act as a probing tool?
Ryan Thomas Williams, Ewan Ingleby
Critical Care Medicine
|
August 9, 2003
Healing responses of skin and muscle in critical illness
Dean Thomas Williams, Keith Harding
Critical Care (London, England)
|
August 31, 2021
Tracheostomy for COVID-19: evolving best practice
Thomas Williams, Brendan A McGrath
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
April 6, 2013
The outlook for alemtuzumab in multiple sclerosis
Thomas Williams, Alasdair Coles, Laura Azzopardi
Page
of 15
Search research articles
Search
Showing results (11-20 of 148) with videos related to
Sort By:
Page
of 15
Journal of Indian Philosophy
|
November 1, 2021
The Impact of Navya-Nyāya on Mādhva Vedānta: Vyāsatīrtha and the Problem of Empty Terms
Michael Thomas Williams
Nature Reviews. Neurology
|
September 22, 2022
Beyond ocrelizumab in primary progressive multiple sclerosis
Thomas Williams, Jeremy Chataway
The Lancet. Infectious Diseases
|
January 23, 2025
RSV vaccines: an elixir for healthy ageing?
Harish Nair, Thomas Williams
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 4, 2018
Immune-mediated encephalitis with daclizumab: The final nail
Thomas Williams, Jeremy Chataway
Journal of Medical Case Reports
|
September 21, 2012
Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report
Thomas Williams, John Thorpe
Journal of Visualized Experiments : Jove
|
September 25, 2018
High-throughput Measurement of Dictyostelium discoideum Macropinocytosis by Flow Cytometry
Thomas Williams, Robert R Kay
Frontiers in Research Metrics and Analytics
|
September 22, 2025
The online survey in qualitative research: can AI act as a probing tool?
Ryan Thomas Williams, Ewan Ingleby
Critical Care Medicine
|
August 9, 2003
Healing responses of skin and muscle in critical illness
Dean Thomas Williams, Keith Harding
Critical Care (London, England)
|
August 31, 2021
Tracheostomy for COVID-19: evolving best practice
Thomas Williams, Brendan A McGrath
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
April 6, 2013
The outlook for alemtuzumab in multiple sclerosis
Thomas Williams, Alasdair Coles, Laura Azzopardi
Page
of 15